RWE in Pharma: 5 minutes with…Sreeram Ramagopalan

Written by Sreeram Ramagopalan (F. Hoffmann-La Roche)

In this ‘RWE in Pharma’ interview series, we are putting various pharma experts in the spotlight and asking them to share their insight on how their industry has traditionally employed real-world evidence (RWE), how they envision this changing over the next few years and what their predictions of the impacts of the highly anticipated US FDA RWE Framework may be. The use of RWE in pharma is subject to the peaks and troughs of the world surrounding it and this interview provides crucial insights into this. Our expert for this instalment is Sreeram Ramagopalan, Global Head of Real-World Evidence, Market...

To view this content, please register now for access

It's completely free